Dopamine and serotonin transporter availability in chronic heroin users: A [123I]β-CIT SPECT imaging study

被引：22
作者：
Cosgrove, Kelly P. [1 ,2 ]
Tellez-Jacques, Karen [1 ,2 ]
Pittman, Brian [1 ,2 ]
Petrakis, Ismene [1 ,2 ]
Baldwin, Ronald M. [1 ,2 ]
Tamagnan, Gilles [3 ]
Seibyl, John [3 ]
Kosten, Thomas [4 ]
Staley, Julie K. [1 ,2 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] VACHS, New Haven, CT USA
[3] Inst Neurodegenerat Disorders, New Haven, CT USA
[4] Baylor Coll Med, Houston, TX 77030 USA
来源：
PSYCHIATRY RESEARCH-NEUROIMAGING | 2010年 / 184卷 / 03期
关键词：
Substance abuse; Single photon emission computed tomography (SPECT); Dopamine transporter; Serotonin transporter; I-123; BETA-CIT; CHRONIC MORPHINE TREATMENT; H-3 PAROXETINE BINDING; HUMAN-BRAIN; NONHUMAN-PRIMATES; UPTAKE SITES; ADDICTION; RAT; REPRODUCIBILITY; ASSOCIATION;
D O I：
10.1016/j.pscychresns.2010.08.001
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Dopamine (DA) and serotonin (5-HT) transporter availability in heroin users and healthy controls was measured using [I-123]beta-CIT and SPECT imaging. Heroin users had statistically similar striatal DA and brainstem and diencephalon 5-HT transporter availability compared with controls. No associations between transporter availability and heroin use characteristics were found. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：192 / 195
页数：4
相关论文
共 24 条
[1]   HIGH-AFFINITY [H-3] PAROXETINE BINDING TO SEROTONIN UPTAKE SITES IN HUMAN-BRAIN TISSUE [J].
BACKSTROM, I ;
BERGSTROM, M ;
MARCUSSON, J .
BRAIN RESEARCH, 1989, 486 (02) :261-268
[2]   EVALUATION OF THE MONOAMINE UPTAKE SITE LIGAND [I-123] METHYL 3-BETA-(4-IODOPHENYL)-TROPANE-2-BETA-CARBOXYLATE ([I-123)BETA-CIT) IN NONHUMAN-PRIMATES - PHARMACOKINETICS, BIODISTRIBUTION AND SPECT BRAIN IMAGING COREGISTERED WITH MRI [J].
BALDWIN, RM ;
ZEAPONCE, Y ;
ZOGHBI, SS ;
LAURELLE, M ;
ALTIKRITI, MS ;
SYBIRSKA, EH ;
MALISON, RT ;
NEUMEYER, JL ;
MILIUS, RA ;
WANG, SY ;
STABIN, M ;
SMITH, EO ;
CHARNEY, DS ;
HOFFER, PB ;
INNIS, RB .
NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (05) :597-606
[3]   Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat [J].
Desole, MS ;
Esposito, G ;
Fresu, L ;
Migheli, R ;
Enrico, P ;
Mura, MA ;
DeNatale, G ;
Miele, E ;
Miele, M .
BRAIN RESEARCH, 1996, 723 (1-2) :154-161
[4]  
DI CG, 1988, P NATL ACAD SCI USA, V85, P5274
[5]   EVALUATION OF ULTRAFILTRATION FOR THE FREE-FRACTION DETERMINATION OF SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY (SPECT) RADIOTRACERS - BETA-CIT, IBF, AND IOMAZENIL [J].
GANDELMAN, MS ;
BALDWIN, RM ;
ZOGHBI, SS ;
ZEAPONCE, Y ;
INNIS, RB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (07) :1014-1019
[6]   Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects [J].
Gerra, G ;
Zaimovic, A ;
Moi, G ;
Bussandri, M ;
Delsignore, R ;
Caccavari, R ;
Brambilla, F .
ADDICTION BIOLOGY, 2003, 8 (01) :23-32
[7]   Neuroimaging studies of brain corpus striatum changes among heroin-dependent patients treated with herbal medicine, U'finer™ capsule [J].
Jia, SW ;
Wang, W ;
Liu, Y ;
Wu, ZM .
ADDICTION BIOLOGY, 2005, 10 (03) :293-297
[8]   Striatal dopaminergic and serotonergic markers in human heroin users [J].
Kish, SJ ;
Kalasinsky, KS ;
Derkach, P ;
Schmunk, GA ;
Guttman, M ;
Ang, L ;
Adams, V ;
Furukawa, Y ;
Haycock, JW .
NEUROPSYCHOPHARMACOLOGY, 2001, 24 (05) :561-567
[9]   REGIONAL DISTRIBUTION OF SEROTONERGIC PRESYNAPTIC AND POSTSYNAPTIC MARKERS IN HUMAN-BRAIN [J].
LARUELLE, M ;
MALOTEAUX, JM .
ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 :56-59
[10]   SPECT IMAGING OF DOPAMINE AND SEROTONIN TRANSPORTERS WITH [I-123] BETA-CIT - PHARMACOLOGICAL CHARACTERIZATION OF BRAIN UPTAKE IN NONHUMAN-PRIMATES [J].
LARUELLE, M ;
BALDWIN, RM ;
MALISON, RT ;
ZEAPONCE, Y ;
ZOGHBI, SS ;
ALTIKRITI, MS ;
SYBIRSKA, EH ;
ZIMMERMANN, RC ;
WISNIEWSKI, G ;
NEUMEYER, JL ;
MILIUS, RA ;
WANG, SY ;
SMITH, EO ;
ROTH, RH ;
CHARNEY, DS ;
HOFFER, PB ;
INNIS, RB .
SYNAPSE, 1993, 13 (04) :295-309
123